CYP19A1 and polycystic ovary syndrome: SPX had an inhibitory effect on CYP19A1 expression at 10 and 100 nM in the normal weight, PCOS normal weight, and PCOS obese groups and at doses of 1, 10, and 100 nM in GC of obese women.